期刊文献+

胰腺导管腺癌患者具有较高的腰椎骨髓脂肪含量的影像研究

Pancreatic ductal adenocarcinoma patients have higher levels of vertebral marrow fat content
暂未订购
导出
摘要 目的探讨胰腺导管腺癌腰椎骨髓脂肪含量的变化。方法收集32例经MDCT及病理组织学证实的胰腺导管腺癌患者(年龄41~76岁)及32例人口学匹配的健康受试者行MRI水-脂分离成像获取腰椎骨髓脂肪分数(FF),测定血糖、血脂指标(TC、TG、HDL-c、LDL-c)及胰岛素水平。多元Logistic回归分析胰腺导管腺癌的影响因子。结果胰腺导管腺癌患者FF(67.9%±7.8%)明显高于正常对照组(49.6%±6.5%),且组间血脂指标存在统计学意义(P均<0.05)。Logistic回归分析发现,慢性胰腺炎史及FF是胰腺导管腺癌的危险因素,OR值分别为1.304(95%CI为1.102~1.780)及1.521(95%CI为1.115~2.004)(P均<0.01)。结论胰腺导管腺癌患者具有较高腰椎骨髓脂肪含量。 Objective To investigate the change in verertebral marrow fat content of pancreatic ductal adenocarcinoma (PDAC). Methods PDAC patients (41 -76 years) and healthy controls (n = 32/group) underwent MRI water-fat separation to obtain marrow fat fraction (FF). Ten serum levels of blood glucose, total cholesterol, triglyceride, high density lipoproptein, low density lipoproptein and insulin were measured. Logistic analysis was performed to assess the predictive factors of PDAC. Results The mean FF of PDAC (67.9% ±7.8% ) was higher than that of controls (49.6% ±6.5% ). There were significant differences in levels of blood lipids ( all P 〈 0.05 ). Logistic analysis indicated that chronic pancreatitis and FF were independent correlation factors of PDAC ( OR = 1. 304, 95% CI = 1. 102 - 1. 780 and OR = 1. 521, 95% CI = 1. 115 - 2. 004, respectively) ( all P 〈 0. 01 ). Conclusion PDAC patients have higher levels of vertebral marrow fat content.
出处 《医学影像学杂志》 2017年第2期277-280,共4页 Journal of Medical Imaging
关键词 磁共振成像 水-脂分离 骨髓脂肪 胰腺癌 Magnetic resonance imaging Water-fat separation Marrow fat Pancreatic cancer
  • 相关文献

参考文献8

二级参考文献153

  • 1郑建明,朱明华,倪灿荣,刘晓红,黄玲,李兆申.TGF—β/Smads信号通路相关蛋白在胰腺上皮内瘤变和胰腺癌组织中的表达[J].胰腺病学,2004,4(4):204-209. 被引量:4
  • 2Yu-JunLi Zhi-MinWei Yun-XiaoMeng Xiang-RuiJi.β-catenin up-regulates the expression of cyclinD1, c-myc and MMP-7 in human pancreatic cancer: Relationships with carcinogenesis and metastasis[J].World Journal of Gastroenterology,2005,11(14):2117-2123. 被引量:70
  • 3Compston J.Osteoporosis:social and economic impact.Radiol Clin North Am,2010,48:477-482.
  • 4Liu SP,Liao EY,Chen J,et al.Effects of methylprednisolone on bone mineral density and microarchitecture of trabecular bones in rats with administration time and assessed by micro-computed tomography.Acta Radiol,2009,50:93-100.
  • 5Bolotin HH,Sievanen H.Inaccuracies inherent in dual-energy X-ray absorptiometry in vivo bone mineral density can seriously mislead diagnostic/prognostic interpretations of patient-specific bone fragility.J Bone Miner Res,2001,16:799-805.
  • 6Seeman E,DelmasPD.Bone quality--the material and structural basis of bone strength and fragility.N Engl J Med,2006,354:2250-2261.
  • 7Tang GY,Lv ZW,Tang RB,et al.Evaluation of MR spectrscopy and diffusion-weighted MRI in detecting bone marrow changes in postmenopausal women with osteoporosis.Clin Radiol,2010,65:377-381.
  • 8Griffith JF,Yeung DK,Antonio GE,et al.Vertebral Bone mineral density,marrow perfusion,and fat content in healthy men and men with osteoporosis:dynamic contrast-enhanced MR imaging and MR spectroscopy.Radiology,2005,236:945-951.
  • 9Baofeng L,Zhi Y,Bei C,et al.Characterization of a rabbit osteoporosis model induced by ovariectomy and glucocorticoid.Acts Orthop,2010,81:396-401.
  • 10Casta(n)eda S,Calvo E,Largo R,et al.Characterization of a new experimental model of osteoporosis in rabbits.J Bone Miner Metab,2008,26:53-59.

共引文献77

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部